In the latest trading session, 1.12 million Oncology Institute Inc (NASDAQ:TOI) shares changed hands as the company’s beta touched 0.44. With the company’s most recent per share price at $0.99 changing hands around $0.19 or 23.91% at last look, the market valuation stands at $74.79M. TOI’s current price is a discount, trading about -112.12% off its 52-week high of $2.10. The share price had its 52-week low at $0.13, which suggests the last value was 86.87% up since then.
Analysts gave the Oncology Institute Inc (TOI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TOI as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Oncology Institute Inc’s EPS for the current quarter is expected to be 0.
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI is in green as seen in intraday trades today. With action 3.11%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 220.36%, with the 5-day performance at 3.11% in the green. However, in the 30-day time frame, Oncology Institute Inc (NASDAQ:TOI) is 26.38% up.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 87.62% from its recent market value. According to analyst projections, TOI’s forecast low is 6 with 10 as the target high. To hit the forecast high, the stock’s price needs a -910.1% plunge from its current level, while the stock would need to soar -506.06% for it to hit the projected low.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds the second largest percentage of outstanding shares, with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 1.27 shares estimated at $1.29 million under it, the former controlled 1.69% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.56% of the shares, roughly 422.98 shares worth around $0.43 million.
